Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I5BN
|
|||
| Former ID |
DIB002789
|
|||
| Drug Name |
NV-196
|
|||
| Synonyms |
Triphendiol; NV-196; SCHEMBL2604720; UNII-6I62LZU21D component KQCJZAUNKSGEFM-UNMCSNQZSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Novogen Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H20O4
|
|||
| Canonical SMILES |
COC1=CC=C(C=C1)C2C(COC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O
|
|||
| InChI |
1S/C22H20O4/c1-25-18-9-4-15(5-10-18)22-19-11-8-17(24)12-21(19)26-13-20(22)14-2-6-16(23)7-3-14/h2-12,20,22-24H,13H2,1H3/t20-,22-/m0/s1
|
|||
| InChIKey |
KQCJZAUNKSGEFM-UNMCSNQZSA-N
|
|||
| CAS Number |
CAS 1213777-80-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase 1a safety and pharmacokinetic study of oral NV-196 in patients with solid tumours. J Clin Oncol (Meeting Abstracts) May 2008 vol. 26 no. 15_suppl 14615. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.